These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9009679)

  • 1. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
    Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
    Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local immune response in neurofibromatosis type 1 and type 2].
    Gerosa PL; Vai C; Bizzozero L; Fontana A; Giussani G; Spinelli M
    Minerva Med; 1993 Feb; 84(1-2):23-31. PubMed ID: 8464564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
    Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
    Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
    Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
    Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.
    Lévy P; Ripoche H; Laurendeau I; Lazar V; Ortonne N; Parfait B; Leroy K; Wechsler J; Salmon I; Wolkenstein P; Dessen P; Vidaud M; Vidaud D; Bièche I
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):398-407. PubMed ID: 17202312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors.
    Brooks DG
    Neurosurg Clin N Am; 2004 Apr; 15(2):145-55. PubMed ID: 15177314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model.
    Saito H; Yoshida T; Yamazaki H; Suzuki N
    Oncogene; 2007 Jul; 26(32):4714-9. PubMed ID: 17237809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
    Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
    Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
    Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
    Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetics of neurofibromatosis: recent progress and prospects].
    Maillet-Vioud M; Narod S; Assouline D; Sobol H; Fischer G; Robert JM; Lenoir GM
    Rev Neurol (Paris); 1991; 147(10):644-52. PubMed ID: 1763253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
    Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
    Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
    Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.